Educational research on US and Indian equities, ETFs, mutual funds and crypto, with screeners and a free investing academy.
All data is for educational purposes only and should not be considered investment advice.
Equiscale is operated by Syntellia LLC, a Delaware limited liability company.
© 2026 Syntellia LLC. All rights reserved.
The Joint Corp. operates and is a franchisor and operator of chiropractic clinics in the United States. The company provides services under the franchise agreement, including training of franchisees and staff, site selection, construction/vendor management and ongoing operations support. It operates through a network of franchised clinics, offering routine and affordable chiropractic adjustments using a private pay, non-insurance, cash-based model. The company was incorporated in 2010 and is headquartered in Scottsdale, Arizona.
Rule-based from financial data. Not advice.
5-year financial trends. Figures in USD millions.
Latest fiscal year: 2025
Year-by-year revenue, profitability, and cash flow (USD millions, last 5 years)
| Year | Revenue | EBITDA | Net Profit | FCF | ROE | Rev Growth 1Y | NP Growth 1Y |
|---|---|---|---|---|---|---|---|
| 2025 | $55M | $1M | $3M | $0M | 19.3% | 5.2% | -150.2% |
| 2024 | $52M | $3M | $-6M | $8M | -28.1% | 11.0% | -40.6% |
| 2023 | $47M | $9M | $-10M | $10M | -39.4% | -53.6% | -1656.1% |
| 2022 | $101M | $8M | $1M | $2M | 1.9% | - | - |
| 2021 | - | - | - |
Income statement, balance sheet, and cash flow as reported
Consolidated Figures in USD Millions.
| Metric | 2025 |
|---|---|
| Total Revenue | 54.90 |
| Operating Revenue | 53.06 |
| Cost Of Revenue | 11.23 |
| Gross Profit | 43.67 |
| Operating Expense | 44.58 |
| Selling General And Administration | 42.93 |
| Total Expenses | 55.80 |
| Operating Income | -0.91 |
| Total Operating Income As Reported | -0.91 |
| EBITDA | 0.81 |
| Normalized EBITDA | 0.82 |
| EBIT | -0.91 |
| Other Non Operating Income Expenses | 0.68 |
| Other Income Expense | 0.68 |
| Pretax Income | -0.23 |
| Tax Provision | 0.04 |
| Tax Rate For Calcs | 0 |
| Tax Effect Of Unusual Items | 0 |
| Net Income Continuous Operations | -0.27 |
| Net Income From Continuing And Discontinued Operation | 2.91 |
| Net Income From Continuing Operation Net Minority Interest | -0.27 |
| Net Income | 2.91 |
| Net Income Common Stockholders | 2.91 |
| Net Income Including Noncontrolling Interests | 2.91 |
| Normalized Income | -0.26 |
| Diluted NI Availto Com Stockholders | 2.91 |
| Basic Average Shares | 15.13 |
| Diluted Average Shares | 15.13 |
| Reconciled Depreciation | 1.71 |
| Reconciled Cost Of Revenue | 11.16 |
| Total Unusual Items | -0.01 |
| Total Unusual Items Excluding Goodwill | -0.01 |
| Net Income Discontinuous Operations | 3.18 |
| Special Income Charges | -0.01 |
| Depreciation Amortization Depletion Income Statement | 1.64 |
| Depreciation And Amortization In Income Statement | 1.64 |
| General And Administrative Expense | 29.63 |
| Other Gand A | 29.63 |
| Gain On Sale Of Ppe | -0.01 |
| Selling And Marketing Expense | 13.30 |
Healthcare sector peers, ranked by market cap
| Company | Ticker | Market Cap | P/E | P/B | ROE | EV/EBITDA |
|---|---|---|---|---|---|---|
| The Joint Corp.this co. | JYNT | $117M | 40.32 | 7.80 | 19.3% | 118.19 |
| AVITA Medical, Inc. | RCEL | $134M | -2.76 | -8.06 | 291.8% | -4.12 |
| SANUWAVE Health, Inc. | SNWV | $132M | 11.20 | 81.74 | 729.6% | 7.38 |
| MaxCyte, Inc. | MXCT | $132M | -2.95 | 0.77 | -26.0% | -3.23 |
| Aldeyra Therapeutics, Inc. | ALDX | $106M | -3.14 |
| - |
| - |
| - |
| - |
| 2.40 |
| -76.5% |
| -1.63 |
| Cardiff Oncology, Inc. | CRDF | $106M | -2.31 | 2.33 | -101.0% | -1.86 |
| Neuronetics, Inc. | STIM | $102M | -2.61 | 4.54 | -174.3% | -5.84 |
| OptimizeRx Corporation | OPRX | $101M | 19.67 | 0.79 | 4.0% | 6.26 |
| Definitive Healthcare Corp. | DH | $96M | -0.69 | 0.34 | -49.4% | -0.74 |
| Peer Median | - | -2.46 | 1.56 | -37.7% | -1.74 | |